Back

Imaging endpoints in cardiac amyloidosis therapy: current state and future outlook.

9 December 2021 (14:40 - 14:50)
Organised by:
Congress Presentation Part of: Management of cardiac amyloid guided by multimodality imaging: the paradigm has shifted Cross-Modality and Multi-Modality Imaging Topics, Other EACVI Premium Access EuroEcho 2021

About the speaker

Photo
Professor Marianna Fontana

University College London, London (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
From clinical to multimodality imaging: red flags in cardiac amyloidosis diagnosis.
Doctor P. Soman (Pittsburgh, US)
Slides Video
Presentation thumbnail
Imaging to define cardiac amyloidosis prognosis: practical implications.
Doctor S. Dorbala (Boston, US)
Slides Video
Presentation thumbnail
Management of cardiac amyloid guided by multimodality imaging: the paradigm has shifted - discussion.
Video

Access the full session

Session thumbnail
Management of cardiac amyloid guided by multimodality imaging: the paradigm has shifted
Video

The Event

Event poster

EuroEcho 2021

9 December 2021 14:40 CET
You may be interested in
thumbnail
Webinar
Diagnosing and treating cardiac amyloidosis
17 November 2022
thumbnail
Congress Presentation
Effects of tafamidis on quantification of myocardial amyloid deposits in patients with transthyretin amyloid cardiomyopathy
30 June 2021
thumbnail
Congress Presentation
Changes over time in AI-based echocardiographic metrics before and after therapy in ATTR cardiomyopathy
31 August 2026
thumbnail
Congress Presentation
Development of cardiac amyloidosis: potential early indicators from a retrospective longitudinal CMR pilot study
10 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources